North America Glucose Monitoring Devices Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2030 - Regional Analysis - By Type (Continuous Glucose Monitoring Devices and Self-Glucose Monitoring Devices), Application (Type 1 Diabetes and Type 2 Diabetes), Testing Type (Fingertip Testing and Alternate Site Testing), and End User (Healthcare Settings and Self/Homecare)

No. of Pages: 99    |    Report Code: BMIRE00029122    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Glucose Monitoring Devices Market

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Glucose Monitoring Devices Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Glucose Monitoring Devices Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increase in The Prevalence of Diabetes in emerging economies to boost the market growth
5.2 Market Opportunities
  • 5.2.1 The Growing Demand for Glucose Monitoring Devices to propel the uptake
5.3 Future Trends
  • 5.3.1 Emergence of integrated devices with efficient connectivity solutions to offer lucrative opportunities in the market
5.4 Impact of Drivers and Restraints

6. North America Glucose Monitoring Devices Market Regional Analysis

6.1 North America Glucose Monitoring Devices Market Overview
6.2 North America Glucose Monitoring Devices Market Revenue 2020-2030 (US$ Million)
6.3 North America Glucose Monitoring Devices Market Forecast Analysis

7. North America Glucose Monitoring Devices Market Analysis – by Type

7.1 Continuous Glucose Monitoring Devices
  • 7.1.1 Overview
  • 7.1.2 Continuous Glucose Monitoring Devices: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Self-Glucose Monitoring Devices
  • 7.2.1 Overview
  • 7.2.2 Self-Glucose Monitoring Devices: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Glucose Monitoring Devices Market Analysis – by Application

8.1 Type 1 Diabetes
  • 8.1.1 Overview
  • 8.1.2 Type 1 Diabetes: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
8.2 Type 2 Diabetes
  • 8.2.1 Overview
  • 8.2.2 Type 2 Diabetes: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)

9. North America Glucose Monitoring Devices Market Analysis – by Testing Type

9.1 Fingertip Testing
  • 9.1.1 Overview
  • 9.1.2 Type 2 Diabetes: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
9.2 Alternate Site Testing
  • 9.2.1 Overview
  • 9.2.2 Type 2 Diabetes: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)

10. North America Glucose Monitoring Devices Market – North America Analysis

10.1 North America
  • 10.1.1 North America Glucose Monitoring Devices Market Breakdown, by Key Country, 2023 and 2030 (%)
  • 10.1.1.1 North America Glucose Monitoring Devices Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.1.1 US: North America Glucose Monitoring Devices Market Breakdown, by Type
    • 10.1.1.1.2 US: North America Glucose Monitoring Devices Market Breakdown, by Application
    • 10.1.1.1.3 US: North America Glucose Monitoring Devices Market Breakdown, by Testing Type
  • 10.1.1.2 Canada: North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.2.1 Canada: North America Glucose Monitoring Devices Market Breakdown, by Type
    • 10.1.1.2.2 Canada: North America Glucose Monitoring Devices Market Breakdown, by Application
    • 10.1.1.2.3 Canada: North America Glucose Monitoring Devices Market Breakdown, by Testing Type
  • 10.1.1.3 Mexico : North America Glucose Monitoring Devices Market – Revenue and Forecast to 2030 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Glucose Monitoring Devices Market Breakdown, by Type
    • 10.1.1.3.2 Mexico : North America Glucose Monitoring Devices Market Breakdown, by Application
    • 10.1.1.3.3 Mexico : North America Glucose Monitoring Devices Market Breakdown, by Testing Type

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Glucose Monitoring Devices Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 B. Braun SE
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 F. Hoffmann-La Roche Ltd
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 LifeScan Inc
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 Medtronic Plc
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Abbott Laboratories
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Ypsomed Holding AG
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 Senseonics Holdings Inc
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Nipro Corp
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 GE HealthCare Technologies Inc
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Terumo Corp
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Glucose Monitoring Devices Market

  • B. Braun SE
  • F. Hoffmann-La Roche Ltd
  • LifeScan Inc
  • Medtronic Plc
  • Abbott Laboratories
  • Ypsomed Holding AG
  • Senseonics Holdings Inc
  • Nipro Corp
  • GE HealthCare Technologies Inc
  • Terumo Corp